[HTML][HTML] Potential strategies for combating COVID-19
S Shamim, M Khan, ZJ Kharaba, M Ijaz, G Murtaza - Archives of virology, 2020 - Springer
Coronavirus disease 2019, also known as COVID-19, is caused by a novel coronavirus
named severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. The infection has …
named severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. The infection has …
The current understanding and potential therapeutic options to combat COVID-19
The ongoing wreaking global outbreak of the novel human beta coronavirus (CoV)
pathogen was presumed to be from a seafood wholesale market in Wuhan, China, belongs …
pathogen was presumed to be from a seafood wholesale market in Wuhan, China, belongs …
Stem cell therapy in coronavirus disease 2019: current evidence and future potential
R Shetty, P Murugeswari, K Chakrabarty, C Jayadev… - Cytotherapy, 2021 - Elsevier
The end of 2019 saw the beginning of the coronavirus disease 2019 (COVID-19) pandemic
that soared in 2020, affecting 215 countries worldwide, with no signs of abating. In an effort …
that soared in 2020, affecting 215 countries worldwide, with no signs of abating. In an effort …
[HTML][HTML] Potential therapeutic options for COVID-19: an update on current evidence
Abstract SARS-CoV-2, a novel coronavirus, is the agent responsible for the COVID-19
pandemic and is a major public health concern nowadays. The rapid and global spread of …
pandemic and is a major public health concern nowadays. The rapid and global spread of …
[HTML][HTML] COVID-19 pandemic and the convalescent plasma therapy: possible benefits and risks
R Noor, N Tasnim, C Saha - Current clinical microbiology reports, 2021 - Springer
Purpose of Review COVID-19 pandemic has been the major threat to the global public
health for a year (last of 2019–till date); and unfortunately, there is still as no specific antiviral …
health for a year (last of 2019–till date); and unfortunately, there is still as no specific antiviral …
[HTML][HTML] Pandemic COVID-19: Current status and challenges of antiviral therapies
W Chan, B He, X Wang, ML He - Genes & Diseases, 2020 - Elsevier
The pandemic COVID-19, caused by a new coronavirus SARS-CoV-2 infection, has infected
over 12 million individuals and caused more than 55,200 death worldwide. Currently, there …
over 12 million individuals and caused more than 55,200 death worldwide. Currently, there …
Emergence of ancient convalescent plasma (CP) therapy: to manage COVID-19 pandemic
Since December 2019, the human populations of the 195 global countries continue
experiencing grave health and life threats due to the current COVID-19 pandemic. As a …
experiencing grave health and life threats due to the current COVID-19 pandemic. As a …
[HTML][HTML] Cellular therapy: the hope for covid-19
S Nobari, M Rezvan, F Dashtestani… - Avicenna Journal of …, 2022 - ncbi.nlm.nih.gov
Coronaviruses (CoVs) are a group of very diverse viruses that cause a broad spectrum of
diseases from mild to severe enteric, respiratory, systemic diseases, and common cold or …
diseases from mild to severe enteric, respiratory, systemic diseases, and common cold or …
[HTML][HTML] Emerging therapeutic strategies for COVID-19 patients
Abstract Over 100,000 cases of COVID-19 patients infected with the novel coronavirus
SARS-COV-2 have been reported worldwide in approximately 2 months, resulting in over …
SARS-COV-2 have been reported worldwide in approximately 2 months, resulting in over …
[HTML][HTML] Convalescent plasma: A possible treatment of COVID-19 in India
JAT da Silva - Medical journal, Armed Forces India, 2020 - ncbi.nlm.nih.gov
According to statistics by John Hopkins University (JHU) of Medicine, SARS-CoV-2
viruseinduced coronavirus disease 2019 (COVID-19) has, to date (April 22, 2020), infected …
viruseinduced coronavirus disease 2019 (COVID-19) has, to date (April 22, 2020), infected …